A predictive model for prognostic risk stratification of early-stage NSCLC based on clinicopathological and miRNA panel.
Lisha YingTingting LuYiping TianHui GuoConghui WuChen XuJiaoyue JinRui ZhuPan LiuYing YangChaodan YangWenyu DingChenyang XuMinran HuangZhengxiao MaYuting ZhangYue ZhuoRuiyang ZouDan SuPublished in: Lung cancer (Amsterdam, Netherlands) (2024)
The combined model based on CP panel and serum 8-miRNA panel allows better prognostic risk stratification of patients with early-stage NSCLC to predict risk of OS.